Login / Signup

The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulations.

Briony LarancePaul DietzeRobert AliNicholas LintzerisNancy WhiteRebecca JenkinsonLouisa Degenhardt
Published in: Drug and alcohol review (2015)
The introduction of BNX film in Australia varied across States. A perception of restricted choice in medication may have undermined initial acceptance in SA.
Keyphrases
  • room temperature
  • reduced graphene oxide
  • chronic pain
  • pain management
  • healthcare
  • stem cells
  • gold nanoparticles
  • mesenchymal stem cells
  • bone marrow
  • ionic liquid